Thursday - April 23, 2026

Cali Residential Treatment Launches Statewide Directory of California Residential Addiction Treatment Facilities Covering All 58 Counties With Free 24/7 Helpline

California Residential Drug and Alcohol Treatment Logo Comprehensive new resource gives individuals and families instant access to more than 2,000 licensed residential rehab facilities across California — including drug rehab, alcohol rehab, medical detox, and dual diagnosis treatment programs — … Continue reading

Laser Welding Machine Market on Track to More than Double by 2033, Fuelled by Electric Vehicle Surge and Precision Manufacturing Demand

Laser Welding Machine Market From battery assembly lines to aerospace fabrication, laser welding technology is becoming an indispensable pillar of modern industrial production — and the growth numbers reflect it. The Global Laser Welding Machine Industry is undergoing one of … Continue reading

Die Cutting Hydraulic Press Market to Reach 486,959 Units by 2033 as Non-Metallic Applications and Precision Manufacturing Reshape Industry Demand

Die Cutting Hydraulic Press Market Steady volume-driven expansion is underway in the hydraulic press die-cutting industry, underpinned by growing applications across packaging, medical disposables, automotive, and electronics manufacturing. April 23, 2026 — The global die-cutting hydraulic press industry is charting … Continue reading

New York No Fault Doctors – Parkchester Opens Its Doors, Serving Car Accident and Workplace Injury Patients Across The Eastern Bronx

New York No Fault Doctors – Parkchester is now serving the Bronx community. New York No Fault Doctors – Parkchester offers a full spectrum of injury-focused medical services under one roof. BRONX, NY – New York No Fault Doctors is proud … Continue reading

Idiopathic Pulmonary Fibrosis Pipeline Progresses as 80+ Pharma Companies Advance Novel Lung Disease Therapies, Finds DelveInsight | Bristol-Myers Squibb, Genentech, Tvardi Therapeutics, Melius Pharma

Idiopathic Pulmonary Fibrosis Pipeline Insight There are 80+ key companies, including Bristol-Myers Squibb, Genentech, Tvardi Therapeutics, Melius Pharma, Resproly, and others, developing therapies for Idiopathic Pulmonary Fibrosis, with Bristol-Myers Squibb having its IPF drug candidate in the most advanced Phase … Continue reading

B-cell Lymphoma Pipeline Grows as 295+ Pharma Companies Advance Novel Lymphoma Therapies, Finds DelveInsight | Bristol Myers Squibb, Roche, Nektar Therapeutics, Miltenyi Biotec

B-cell Lymphoma Pipeline Insight There are 295+ key companies, including Bristol Myers Squibb, Roche, Nektar Therapeutics, Miltenyi Biotec, and others, developing therapies for B-cell Lymphoma, with several candidates such as Lisocabtagene maraleucel in the advanced Phase III stage. DelveInsight’s “B-cell … Continue reading